CIK 0000879169
- Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943136539
- Phone
- +1 302-498-6700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,959,897
- in 5 filings, $33.0M under 10b5-1 plans
Net −$32,959,897. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-15 | Denton Sheila A. EVP & General Counsel | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −3,330 | 9,993 | ||
| 2025-07-15 | Denton Sheila A. EVP & General Counsel | Grant or award · Performance Shares 10b5-1 | +20,461 | 20,461 | ||
| 2025-07-15 | Denton Sheila A. EVP & General Counsel | Grant or award · Employee Stock Option (right to buy) 10b5-1 | +18,419 | 18,419 | ||
| 2025-07-15 | Issa Mohamed Khairie EVP, Head of US Oncology | Grant or award | +8,769 | 85,252 | ||
| 2025-07-15 | Issa Mohamed Khairie EVP, Head of US Oncology | Grant or award · Performance Shares | +21,923 | 21,923 | ||
| 2025-07-15 | Issa Mohamed Khairie EVP, Head of US Oncology | Grant or award · Employee Stock Option (right to buy) | +19,735 | 19,735 | ||
| 2025-07-15 | Trotta Matteo EVP, GM, Dermatology US | Shares withheld for taxes | −182 | $68.25 | $12K | 9,755 |
| 2025-07-15 | Trotta Matteo EVP, GM, Dermatology US | Grant or award | +5,261 | 15,016 | ||
| 2025-07-15 | Trotta Matteo EVP, GM, Dermatology US | Grant or award · Performance Shares | +13,154 | 13,154 | ||
| 2025-07-15 | Trotta Matteo EVP, GM, Dermatology US | Grant or award · Employee Stock Option (right to buy) | +11,841 | 11,841 | ||
| 2025-07-15 | Heeson Lee EVP, Head of Incyte Intl | Grant or award · Performance Shares | +6,577 | 6,577 | ||
| 2025-07-15 | Morrissey Michael James EVP, Head of Tech. Operations | Grant or award · Performance Shares | +10,961 | 10,961 | ||
| 2025-07-15 | CAGNONI PABLO J President, R&D | Shares withheld for taxes | −2,628 | $68.25 | $179K | 217,262 |
| 2025-07-15 | CAGNONI PABLO J President, R&D | Grant or award | +17,538 | 234,800 | ||
| 2025-07-15 | CAGNONI PABLO J President, R&D | Grant or award · Performance Shares | +43,846 | 43,846 | ||
| 2025-07-15 | CAGNONI PABLO J President, R&D | Grant or award · Employee Stock Option (right to buy) | +39,471 | 39,471 | ||
| 2025-07-15 | Stein Steven H EVP & Chief Medical Officer | Shares withheld for taxes 10b5-1 | −1,596 | $68.25 | $109K | 94,315 |
| 2025-07-15 | Stein Steven H EVP & Chief Medical Officer | Grant or award 10b5-1 | +12,277 | 106,592 | ||
| 2025-07-15 | Stein Steven H EVP & Chief Medical Officer | Grant or award · Performance Shares 10b5-1 | +30,692 | 30,692 | ||
| 2025-07-15 | Stein Steven H EVP & Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) 10b5-1 | +27,629 | 27,629 |
Page 17 of 25 · 500 trades